European Molecular Biology Laboratory, EMBL Rome - Epigenetics and Neurobiology Unit, via E. Ramarini 32, 00015, Monterotondo, Italy.
Therapeutics Discovery, Pharmaceutical Companies of Johnson & Johnson, Janssen Research & Development, Turnhoutseweg 30, 2340, Beerse, Belgium.
Sci Rep. 2022 Oct 10;12(1):16974. doi: 10.1038/s41598-022-20906-0.
Progress in the generation of Hematopoietic Stem and Progenitor Cells (HSPCs) in vitro and ex vivo has been built on the knowledge of developmental hematopoiesis, underscoring the importance of understanding this process. HSPCs emerge within the embryonic vasculature through an Endothelial-to-Hematopoietic Transition (EHT). The transcriptional regulator Tal1 exerts essential functions in the earliest stages of blood development, but is considered dispensable for the EHT. Nevertheless, Tal1 is expressed with its binding partner Lmo2 and it homologous Lyl1 in endothelial and transitioning cells at the time of EHT. Here, we investigated the function of these genes using a mouse embryonic-stem cell (mESC)-based differentiation system to model hematopoietic development. We showed for the first time that the expression of TAL1 in endothelial cells is crucial to ensure the efficiency of the EHT process and a sustained hematopoietic output. Our findings uncover an important function of Tal1 during the EHT, thus filling the current gap in the knowledge of the role of this master gene throughout the whole process of hematopoietic development.
体外和体内造血干细胞和祖细胞 (HSPC) 的生成进展建立在对发育性造血的认识基础上,突出了理解这一过程的重要性。HSPC 是通过内皮细胞向造血细胞的过渡 (EHT) 在胚胎血管系统中出现的。转录调节因子 Tal1 在血液发育的最早阶段发挥着重要作用,但被认为对 EHT 是可有可无的。然而,在 EHT 时,Tal1 与其结合伙伴 Lmo2 和同源 Lyl1 在血管内皮细胞和过渡细胞中表达。在这里,我们使用基于小鼠胚胎干细胞 (mESC) 的分化系统来研究这些基因的功能,以模拟造血发育。我们首次表明,内皮细胞中 TAL1 的表达对于确保 EHT 过程的效率和持续的造血输出至关重要。我们的发现揭示了 Tal1 在 EHT 过程中的重要功能,从而填补了当前关于该主基因在造血发育全过程中作用的知识空白。